Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, et al. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology 2023 Apr 6. doi: 10.1097/HEP.0000000000000395.
PMID: 37386786